Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PAQR8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EHMT1-IT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF879 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PATZ1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAOX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF787 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACTIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIK3C2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF126P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZDHHC24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL2L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC71L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JARID2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAS2R13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAPBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGEF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on